Elena Moro

Active 1999–2026

148
Papers
18,260
Citations
78
h-index
133
i10-index

Citations

Citations per year for Elena Moro1984: 3 citations1985: 3 citations1986: 3 citations1987: 5 citations1988: 5 citations1989: 2 citations1990: 2 citations1991: 3 citations1992: 1 citations1993: 1 citations1994: 2 citations1995: 6 citations1996: 2 citations1998: 2 citations1999: 2 citations2000: 12 citations2001: 16 citations2002: 52 citations2003: 73 citations2004: 74 citations2005: 64 citations2006: 131 citations2007: 110 citations2008: 134 citations2009: 117 citations2010: 174 citations2011: 147 citations2012: 160 citations2013: 218 citations2014: 189 citations2015: 172 citations2016: 160 citations2017: 168 citations2018: 147 citations2019: 481 citations2020: 573 citations2021: 540 citations2022: 544 citations2023: 430 citations2024: 606 citations2025: 327 citations2026: 16 citations1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,771 citing papers, 23% of this breakdownUnited Kingdom: 683 citing papers, 8.8% of this breakdownGermany: 650 citing papers, 8.4% of this breakdownItaly: 499 citing papers, 6.5% of this breakdownCanada: 494 citing papers, 6.4% of this breakdownFrance: 426 citing papers, 5.5% of this breakdownChina: 380 citing papers, 4.9% of this breakdownSpain: 268 citing papers, 3.5% of this breakdownNetherlands: 245 citing papers, 3.2% of this breakdownAustralia: 183 citing papers, 2.4% of this breakdownSwitzerland: 175 citing papers, 2.3% of this breakdownSweden: 119 citing papers, 1.5% of this breakdown
0%23%Other 23.6%

Fields

  • Medicine73.5%
  • Neuroscience17%
  • Biochemistry, Genetics and Molecular Biology3.1%
  • Psychology2.2%
  • Engineering1.3%
  • Health Professions1.3%
  • Other1.6%

Topics

  • Neurological disorders and treatments19.7%
  • Parkinson's Disease Mechanisms and Treatments15.7%
  • Transcranial Magnetic Stimulation Studies5.5%
  • Neuroscience and Neural Engineering5.1%
  • Genetic Neurodegenerative Diseases3.3%
  • Botulinum Toxin and Related Neurological Disorders2.7%
  • Other48%

Coauthors

All papers

Open in search
  1. Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

    Authors: , , , , , , , - The Lancet Neurology 2022 cited by 278

  2. European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

    Authors: , , , , , , , , , , , , , , , , , - Movement Disorders 2022 cited by 175

  3. Deep Brain Stimulation for Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Archives of Neurology 2010 cited by 965

  4. Eight-hours adaptive deep brain stimulation in patients with Parkinson disease

    Authors: , , , , , , , , , , , , - Neurology 2018 cited by 258

  5. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , LeighAnn Persondek, Hanno Ulmer, Verena Rass, Bettina Pfausler, Christoph Müller, Simon Jung, Michael Crean, Sara Meoni, Dániel Bereczki, Tibor Kovács, Netta Agajany, Carmel Armon, Sharon Wolfson, Maria Sofia Cotelli, Elisa Bianchi, A. Riahi, Şerefnur Öztürk, Onur Ural, Gryb Viktoriia, M. I. Lesiv, Luı́s F. Maia, Vanessa Oliveira, Mafalda Seabra, Vanessa Carvalho, Paul Vespa, J. Javier Provencio, DaiWai M. Olson, Claude Hemphill, Chethan P. Venkatasubba Rao, Nerissa Ko, Ericka L. Fink, Courtney Robertson, Michelle E. Schober, Ali Scott, Michal Hammond, Nicole Paul, Aleksandra Safonova, L. Kaplan, Charith Ratnayake, Adytia D Sharma, Abigail Skeel, Carlos Villamizar Rosales, Dominika Dolak, Panayiotis N. Varelas, Lev Lotman, L Kaltenbach, Menon David K. - JAMA Network Open 2021 cited by 415

  6. Sensing data and methodology from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , - npj Parkinson s Disease 2024 cited by 114

  7. Sex differences in movement disorders

    Authors: , , - Nature Reviews Neurology 2020 cited by 213

  8. Beta Oscillatory Activity in the Subthalamic Nucleus and Its Relation to Dopaminergic Response in Parkinson's Disease

    Authors: , , , , , , , - Journal of Neurophysiology 2006 cited by 602

  9. Basic algorithms for the programming of deep brain stimulation in Parkinson's disease

    Authors: , , - Movement Disorders 2006 cited by 428

  10. Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert E. Gross, Harrison C. Walker, Andrés M. Lozano, Benjamin L. Walter, Zoltán Mari, William S. Anderson, Barbara Kelly Changizi, Elena Moro, S. Elizabeth Zauber, Lauren E. Schrock, Jianguo Zhang, Wei Hu, Kyle Rizer, Erin Hastings, Kelly D. Foote, Irene A. Malaty, Wissam Deeb, Aysegul Gunduz, Michael S. Okun - JAMA Neurology 2018 cited by 239

  11. Clinical perspectives of adaptive deep brain stimulation

    Authors: , , , , , , , , , - Brain stimulation 2021 cited by 85

  12. European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies

    Authors: , , , , , , , , , , , , , , , , , - European Journal of Neurology 2022 cited by 103

  13. Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia

    Authors: , , , , , , , , , - Neurology 2017 cited by 251

  14. Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies

    Authors: , , , , , - Movement Disorders 2022 cited by 101

  15. Unprecedented increase of West Nile virus neuroinvasive disease, Spain, summer 2020

    Authors: , , , , , , , , , , , , , , , , , , , , - Eurosurveillance 2021 cited by 84

  16. Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease

    Authors: , , , , , , , , , , - npj Parkinson s Disease 2021 cited by 81

  17. Pedunculopontine nucleus deep brain stimulation in Parkinson's disease: A clinical review

    Authors: , , , , , , , , , , , , , , , , , , - Movement Disorders 2017 cited by 229

  18. Medical and surgical management of advanced Parkinson's disease

    Authors: , , , - Movement Disorders 2018 cited by 182

  19. Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , - Annals of Neurology 2020 cited by 86

  20. Deep brain stimulation: is it time to change gears by closing the loop?

    Authors: , , , , , , , , , - Journal of Neural Engineering 2021 cited by 40

  21. Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2006 cited by 977

  22. Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Massimo Scerrati, Marc Janssens, Anthony E. Lang - Movement Disorders 2010 cited by 460

  23. Mood and behavioural effects of subthalamic stimulation in Parkinson's disease

    Authors: , , , - The Lancet Neurology 2014 cited by 332

  24. Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Anatomy and Terminology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Stereotactic and Functional Neurosurgery 2016 cited by 576